Načítá se...
The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer
PURPOSE: The Prostate Health Index (phi) is a new test combining total, free and [-2]proPSA into a single score. It was recently approved by the FDA and is now commercially available in the U.S., Europe and Australia. We investigate whether phi improves specificity for detecting clinically significa...
Uloženo v:
| Vydáno v: | J Urol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4404198/ https://ncbi.nlm.nih.gov/pubmed/25463993 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2014.10.121 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|